Eli Lilly Confirms 'Superior Weight Loss' Of Its Next-Generation Obesity Drug - Investor's Business Daily
business 2026/03/19 21:08:00

Eli Lilly Confirms 'Superior Weight Loss' Of Its Next-Generation Obesity Drug - Investor's Business Daily

Source:Investor's Business Daily
Author:None

Patients taking retatrutide, lost 16.8% of their body weight over 40 weeks.